The largest database of trusted experimental protocols

3 protocols using df6251

1

Protein Expression in Ischemic Penumbra

Check if the same lab product or an alternative is used in the 5 most similar protocols
Proteins from ischemic penumbral tissues and HAPI cells were used for Western blot analysis. SDS-PAGE was performed, and the resolved proteins were transferred onto polyvinylidene fluoride (PVDF) membranes by electroblotting. The membranes were blocked at Tris–buffered saline (TBST) containing 5% non-fat milk powder for 2 h and then incubated with the following primary antibodies overnight at 4°C: Arg1 (1:500, GTX109242, GeneTex), CD163 (1:500, WH112776, ABclonal), iNOS (1:500, GTX130246, GeneTex), CD86 (1:500, WH141312, ABclonal), P62 (1:200, WH146703, ABclonal), IRF5 (1:1000, ab181553, Abcam), TRAF6 (1:200, sc-8409, Santa Cruz), IKKαβ (1:200, BM4499, Boster), IL-10 (1:200, 20850-1-AP, Proteintech), IL-4 (1:500, 66142-1-lg, Proteintech), TNF-α (1:200, YT4689, ImmunoWay), and IL-1β (1:500, DF6251, Affinity). After being washed with TBST 3 times, the membranes were incubated with horseradish peroxidase (HRP)-conjugated goat anti-rabbit/mouse secondary antibodies for 2 h at RT. β-actin was used as a loading control. Immunoreactive bands were detected by an enhanced chemiluminescence (ECL) detection system. The gray values of the protein bands were quantified by Image Lab.
+ Open protocol
+ Expand
2

Western Blot Analysis of Exosomes and Inflammatory Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Prepared protein samples (10 μg) were subject to 12% SDS-PAGE, followed by electro-transfer onto PVDF membranes. Then the membranes were blocked in 5% skimmed milk for 1 h. Antibodies against exosome markers CD9 (ab92726; Abcam, Cambridge, UK), CD81 (ab109201; Abcam) and calnexin (ab133615; Abcam) were diluted at a ratio of 1:1000. The inflammatory response of vascular tissue and VSMCs was detected using antibodies against NFATc3 (18222-1-AP, 1:1000 dilution; Proteintech, Wuhan, China) and IL-6 (DF6087, 1:500 dilution; Affinity Biosciences, Cincinnati, USA), IL-1β (DF6251, 1:500 dilution; Affinity Biosciences) and TNF-α (ab205587, 1:500 dilution; Abcam). The internal control anti-β-actin primary antibody (TA-09; Zhongshan Jinqiao Biotechnology, Beijing, China) was used at 1:1000 dilution. The PVDF membranes were incubated with the above primary antibodies at 4°C overnight, followed by incubation with HRP-conjugated goat anti-mouse IgG (ZB-2305, 1:4000; Zhongshan Jinqiao Biotechnology) or HRP-conjugated goat anti-rabbit IgG (ZB-2301, 1:4000; Zhongshan Jinqiao Biotechnology) secondary antibodies for 1 h at room temperature. After extensive wash, protein bands were visualized using ultra high sensitivity ECL kit (HY-K1005; MCE, New Jersey, USA), and images were obtained with a chemiluminescence gel imaging system (12003153; Bio-Rad, Hercules, USA).
+ Open protocol
+ Expand
3

Skin Tissue Protein Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Radioimmunoprecipitation assay (RIPA) buffer was used to split skin tissue proteins. The primary antibodies included TNF-α (1:1000 dilution), Interleukin 1 beta (IL-1β, 1:1000 dilution, DF6251, Affinity Biosciences, Cincinnati, OH, USA), Collagen 1 (COL1, 1:4000 dilution, ab34710, Abcam, Cambridge, UK), vimentin (1:4000 dilution), N-Cadherin (1:1000 Dilution, ARG23870, Arigo, Shanghai, China), and GAPDH (1:10,000 dilution, ab181602, Abcam, Cambridge, UK). They were then incubated with goat anti-rabbit or anti-mouse secondary antibodies (074–1506/074-1806, Kirkegaard and Perry Laboratories, Gaithersburg, MD, USA). The target bands were visualized using ECL Prime Western Blotting Detection Reagent (ZD310A, ZomanBio, Beijing, China). GAPDH was used as an internal reference.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!